Become a Member

written by reader Caronavirus stocks courtesy of Laissez Faire letter

By aldosov, February 29, 2020

MRNA, GILD, INO…

This is a discussion topic or guest posting submitted by a Stock Gumshoe reader. The content has not been edited or reviewed by Stock Gumshoe, and any opinions expressed are those of the author alone.

guest

12345

This site uses Akismet to reduce spam. Learn how your comment data is processed.

7 Comments
Inline Feedbacks
View all comments
rohtsc711
rohtsc711
February 29, 2020 12:26 pm

Just a few ideas to hedge our crashing market:
“CODX”, maker of diagnostic kits for Covid-19 could go vertical once approved by FDA/CDC. The stock has already jumped 400% on news that their patented test kits offer results in 45-min, as opposed to 48-hours to send samples for testing at various state labs. They also advertise to be more accurate than the CDC tests, which have already given some “false-positives”.
“TOMZ”, is also under the radar, maker of sterilization machines, already approved/adopted by China. Could be in high demand if the virus spreads as rapidly in the U.S.
There is a slew of vaccine makers jumping on the bandwagon to develop a successful vaccine, but to the victor will go the spoils of that race. Even Israel has recently promised they will have a valid vaccine in “weeks”, but most virologist view that as a small miracle since animal testing, human testing Phase I/II/III would require months per phase before approval for mass production.

Add a Topic
5555
👍 4
vgudipati
March 1, 2020 2:57 pm
Reply to  rohtsc711

Also, checkout Ligand (LGND). The stock just started spiking on Friday’s news that company CEO made a statement that it is helping find a cure for the coronovirus. Can someone with an insight on the company’s products make comment on efficacy of the company to produce the vaccine for the virus? Is this stock good to own?

Add a Topic
3413
👍 5
Travis Johnson, Stock Gumshoe
March 2, 2020 9:34 am
Reply to  vgudipati

They’re not a vaccine maker, it seems likely that their exposure would be minor to any possible treatments — most likely partnering with Gilead to make their drugs easier to deliver via IV (using captisol), but there are a lot of drugs in their potential pipeline of royalties so maybe there’s something in there I’m unaware of.

👍 21718
vgudipati
March 5, 2020 10:55 pm

Thanks, Travis. The stock has been moving higher and higher from the past few days or so. Is it something we can nibble at this point?

👍 5
rohtsc711
rohtsc711
March 3, 2020 11:41 am
👍 4
rohtsc711
rohtsc711
March 6, 2020 8:37 am

CEO of Co-Diagnostics $CODX was on Varney (FBN) on 3/5 mentioning the fact that recent relaxation of FDA restrictions now allow them to ship test kits to any CL1A lab in the U.S.. When asked if his company can keep up with demand, he stated that the current capacity from their facility in Utah is 50,000 kits daily, and once their facility in India comes on line, that capacity will triple. (These kits are not cheap).

Add a Topic
9799

We use cookies on this site to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies.

More Info  
34
0
Would love your thoughts, please comment.x
()
x